With immunostaining, we confirmed the presence of CD44+ microglia (also TMEM119+) in EPN and AEP tumor sections, indicating that some CD44+ TAMs were tissue-resident microglia or their derivatives (Fig. 3h). The gene discussed is CD44; the disease is neoplasm.